RedHill Biopharma Ltd. (RDHL)
NASDAQ: RDHL · Real-Time Price · USD
1.040
+0.010 (0.97%)
At close: Apr 28, 2026, 4:00 PM EDT
1.030
-0.010 (-0.96%)
After-hours: Apr 28, 2026, 5:14 PM EDT
RedHill Biopharma Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2016 |
| Revenue | 0.29 | 8.04 | 6.53 | 61.8 | 85.76 | Upgrade
|
| Revenue Growth (YoY) | -96.44% | 23.17% | -89.43% | -27.94% | 33.25% | Upgrade
|
| Cost of Revenue | - | 3.19 | 3.46 | 33.34 | 49.41 | Upgrade
|
| Gross Profit | 0.29 | 4.85 | 3.07 | 28.46 | 36.35 | Upgrade
|
| Selling, General & Admin | 6.17 | 15.52 | 30.98 | 64.03 | 87.99 | Upgrade
|
| Research & Development | 2.02 | 1.59 | 3.53 | 7.28 | 29.5 | Upgrade
|
| Other Operating Expenses | - | - | -8.56 | - | - | Upgrade
|
| Operating Expenses | 8.2 | 17.11 | 25.94 | 71.31 | 117.49 | Upgrade
|
| Operating Income | -7.91 | -12.25 | -22.87 | -42.84 | -81.14 | Upgrade
|
| Interest Expense | -1.46 | -0.06 | -0.37 | -41.33 | -16.57 | Upgrade
|
| Interest & Investment Income | - | 0.13 | 0.09 | 0.14 | 0.05 | Upgrade
|
| Earnings From Equity Investments | -0.03 | - | - | - | - | Upgrade
|
| Currency Exchange Gain (Loss) | - | -0.03 | -0.12 | -0.04 | -0.03 | Upgrade
|
| Other Non Operating Income (Expenses) | 1.32 | 6.3 | -7.45 | 12.41 | -0.07 | Upgrade
|
| EBT Excluding Unusual Items | -8.08 | -5.91 | -30.71 | -71.67 | -97.74 | Upgrade
|
| Gain (Loss) on Sale of Assets | - | - | 35.5 | - | - | Upgrade
|
| Other Unusual Items | - | -2.36 | 19.13 | - | - | Upgrade
|
| Pretax Income | -8.08 | -8.27 | 23.92 | -71.67 | -97.74 | Upgrade
|
| Earnings From Continuing Operations | -8.08 | -8.27 | 23.92 | -71.67 | -97.74 | Upgrade
|
| Earnings From Discontinued Operations | 7.65 | - | - | - | - | Upgrade
|
| Net Income | -0.43 | -8.27 | 23.92 | -71.67 | -97.74 | Upgrade
|
| Net Income to Common | -0.43 | -8.27 | 23.92 | -71.67 | -97.74 | Upgrade
|
| Shares Outstanding (Basic) | - | 1 | 0 | 0 | 0 | Upgrade
|
| Shares Outstanding (Diluted) | - | 1 | 0 | 0 | 0 | Upgrade
|
| Shares Change (YoY) | - | 375.56% | 320.45% | 32.46% | 27.72% | Upgrade
|
| EPS (Basic) | - | -6.71 | 92.30 | -1162.89 | -2100.80 | Upgrade
|
| EPS (Diluted) | - | -6.71 | 92.30 | -1162.89 | -2100.80 | Upgrade
|
| Free Cash Flow | -7.2 | -9.38 | -35.83 | -29.38 | -65.16 | Upgrade
|
| Free Cash Flow Per Share | - | -7.61 | -138.28 | -476.76 | -1400.52 | Upgrade
|
| Gross Margin | 100.00% | 60.31% | 47.03% | 46.06% | 42.39% | Upgrade
|
| Operating Margin | -2765.38% | -152.36% | -350.20% | -69.33% | -94.61% | Upgrade
|
| Profit Margin | -150.00% | -102.80% | 366.25% | -115.97% | -113.98% | Upgrade
|
| Free Cash Flow Margin | -2516.08% | -116.60% | -548.71% | -47.55% | -75.98% | Upgrade
|
| EBITDA | -7.5 | -12.16 | -22.15 | -34.69 | -62.99 | Upgrade
|
| EBITDA Margin | - | -151.14% | - | -56.13% | -73.45% | Upgrade
|
| D&A For EBITDA | 0.41 | 0.1 | 0.71 | 8.15 | 18.15 | Upgrade
|
| EBIT | -7.91 | -12.25 | -22.87 | -42.84 | -81.14 | Upgrade
|
| EBIT Margin | - | -152.36% | - | -69.33% | -94.61% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.